Allspring Global Investments Holdings, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,638
-75.7%
24,405
-47.4%
0.00%
Q2 2023$60,330
+179.8%
46,408
+278.8%
0.00%
Q1 2023$21,561
-26.9%
12,251
+30.5%
0.00%
Q4 2022$29,481
-41.0%
9,389
-8.0%
0.00%
Q3 2022$50,000
+56.2%
10,205
+31.5%
0.00%
Q2 2022$32,000
-93.0%
7,760
-90.1%
0.00%
-100.0%
Q1 2022$457,000
-37.7%
78,705
-19.5%
0.00%0.0%
Q4 2021$733,00097,7780.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders